SCHEMBL5028525

SCHEMBL5028525

CCCCCCCCCCSc1c(Br)sc(-c2ccc(-c3cccs3)s2)c1SCCCCCCCCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.38
HPGD P15428 3/20 0.35
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 4/20 0.35
GAA P10253 3/20 0.35
MAPT P10636 2/20 0.35
MEN1 O00255 1/20 0.35
STAT6 P42226 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
HIF1A Q16665 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LTA4H P09960 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSD17B10 Q99714 1/20 0.32
HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12360572 0.80 TP53 (0.37) DPP4HPGDKDM4EALDH1A1GAA
SCHEMBL12360571 0.80 TP53 (0.37) DPP4HPGDKDM4EALDH1A1GAA
SCHEMBL5026827 0.79 TP53 (0.36) DPP4HPGDKDM4EALDH1A1GAA
SCHEMBL14264673 0.78 DPP4 (0.43) DPP4HPGDKDM4EALDH1A1GAA
SCHEMBL2254449 0.72 ALDH1A1 (0.44) HPGDALDH1A1MAPTNPC1RAB9A
SCHEMBL13070762 0.71 DPP4 (0.44) DPP4HPGDKDM4EALDH1A1GAA
SCHEMBL2608118 0.71 DPP4 (0.44) DPP4HPGDKDM4EALDH1A1GAA
Heptane SCHEMBL8571539 0.71 KDM4E (0.50) DPP4HPGDKDM4EALDH1A1GAA
SCHEMBL30548370 0.70 KDM4E (0.39) HPGDKDM4EALDH1A1GAAMAPT
SCHEMBL2493159 0.69 DPP4 (0.40) DPP4KDM4EALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1916244-B1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL IND LTD (JP) 2013-12-04 EP disclosed
US-8008425-B2 Thiophene compound having sulfonyl group and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-08-30 US disclosed
US-20090127491-A1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-05-21 US disclosed
EP-1916244-A1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME Nissan Chemical Industries, Ltd. (JP) 2008-04-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090127491-A1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME TST, ABCG2, CBR3 DPP4 2091/4885HPGD 2516/4885KDM4E 2440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.